Characterization of ARB in twins: in-trans frameshift and deep intronic BEST1 variants

Read full text Summarise with VIRAT
Authors: Victor Lin, Eugene Yu-Chuan Kang, Laura Liu, Wei-Chi Wu, Nan-Kai Wang
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Autosomal recessive bestrophinopathy (ARB) typically results from biallelic BEST1 coding variants; however, the role of non-coding variants remains under-investigated. We report dizygotic twins with classic ARB who each initially appeared to carry only one frameshift mutation, later found to harbor a second deep intronic variant in trans. Complete ophthalmologic examination, diagnostic imaging, and electrophysiological study were performed. Genetic analysis included whole-exome sequencing followed by targeted Sanger sequencing of intronic regions, confirming BEST1 variants in five family members. Ten-year-old dizygotic twins presented with bilateral reduced visual acuity, hyperopia in at least one eye of each twin, multifocal yellow-white flecks, subretinal hyperreflective material with interlaminar splitting, and mild subretinal/intraretinal fluid. Electro-oculography revealed severely reduced Arden ratios, while full-field electroretinogram revealed subnormal rod and cone responses. Genetic testing identified in trans compound heterozygous BEST1 variants, a maternally inherited frameshift c.353_362dup and a paternally inherited deep intronic variant c.867+97G>A. Asymptomatic parents were heterozygous carriers. This is the first report of dizygotic twins with ARB carrying compound heterozygous BEST1 mutations consisting of a frameshift and the deep intronic variant c.867+97G>A inherited in trans.

Fields of Study & Subjects

Retinal Development and Disorders Retinal Diseases and Treatments Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
Figshare
Publication date
27 March 2026
Language
EN